4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.70
-0.49 (-4.38%)
At close: Dec 5, 2025, 4:00 PM EST
10.91
+0.21 (1.96%)
After-hours: Dec 5, 2025, 7:24 PM EST
4D Molecular Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -209.18 | -160.87 | -100.84 | -107.49 | -71.32 | -56.69 | |
| Depreciation & Amortization | 7.43 | 6.71 | 5.75 | 3.88 | 3.02 | 1.44 | |
| Loss (Gain) From Sale of Investments | -5.44 | -7.18 | -1.24 | 1.06 | 0.72 | - | |
| Stock-Based Compensation | 24.04 | 26.18 | 19.75 | 17.21 | 13.89 | 5.03 | |
| Other Operating Activities | -0.05 | 0.04 | 0.16 | -0 | 0.09 | 0.02 | |
| Change in Accounts Receivable | - | - | - | 0.05 | 1.44 | -0.51 | |
| Change in Accounts Payable | 3.94 | 0.87 | 0.9 | -1.64 | 2.29 | 0.04 | |
| Change in Unearned Revenue | -0.12 | 0.07 | -0.72 | -3.13 | -14.72 | 0.35 | |
| Change in Other Net Operating Assets | -4.12 | -0.4 | 0.45 | 3.39 | -4.54 | -0.59 | |
| Operating Cash Flow | -183.5 | -134.59 | -75.79 | -86.69 | -69.13 | -50.91 | |
| Capital Expenditures | -1.56 | -3.79 | -2.77 | -11.54 | -9.11 | -1 | |
| Investment in Securities | 44.49 | -298.65 | 118.49 | -5.51 | -163.57 | - | |
| Investing Cash Flow | 42.93 | -302.44 | 115.72 | -17.05 | -172.68 | -1 | |
| Issuance of Common Stock | 1.58 | 337.25 | 156.83 | 3.55 | 118.09 | 206.52 | |
| Other Financing Activities | - | - | - | -0.47 | - | -3.14 | |
| Financing Cash Flow | 1.58 | 337.25 | 156.83 | 3.09 | 118.09 | 278.98 | |
| Net Cash Flow | -138.98 | -99.77 | 196.76 | -100.65 | -123.73 | 227.07 | |
| Free Cash Flow | -185.05 | -138.37 | -78.56 | -98.22 | -78.24 | -51.91 | |
| Free Cash Flow Margin | -154209.17% | -373975.68% | -379.11% | -3139.05% | -433.77% | -381.35% | |
| Free Cash Flow Per Share | -3.31 | -2.56 | -2.01 | -3.04 | -2.82 | -8.07 | |
| Levered Free Cash Flow | -103.55 | -82.29 | -46.48 | -59.7 | -41 | -29.23 | |
| Unlevered Free Cash Flow | -103.55 | -82.29 | -46.48 | -59.7 | -41 | -29.23 | |
| Change in Working Capital | -0.3 | 0.54 | 0.63 | -1.34 | -15.53 | -0.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.